Läkemedelsverket
New CMO strengthens Lipum ahead of continued clinical development
Lipum is in the final stages of the Phase I clinical study with SOL-116. At the same time, the company is starting preparations for...
All the pieces in place for Dicot during Q2
Uppsala-based Dicot continues to take decisive steps in...
Dicot's CEO on TO4 and preparations for phase I
With the month of August in sight, pharmaceutical company Dicot...
Dicot heads into summer with a strengthened team and cash flow
In August, Dicot is expected to take its largest...
Elicera Therapeutics on the Danish Medicines Agency's conditional approval
At the end of April, gene and cell therapy company Elicera received...
Drug shortages a difficult problem to manage
The number of over-listed medicines in Sweden increased by over...
News roundup Wednesday July 6
The latest from BioStock
The Ukraine crisis – an ethical dilemma for the life science sector
Russia's inhumane invasion of Ukraine is putting pressure on the life science sector....
BioStock Studio: Idogen receives approval for Phase I/IIa study with IDO 8
Yesterday, the cell therapy company Idogen announced that the Swedish Medical Products Agency has approved its...
Toleranzia increases the pace
Toleranzia has held a...
Toleranzia has had a successful meeting with the Medical Products Agency
Drug developer Toleranzia continues to advance the TOL2 project in preparation...
BiBBInstruments resumes important clinical studies
Cancer diagnostics company BibbInstruments published its annual report for...